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Background: A uterine transplantation is a non-vital, quality-of-life enhancing solid organ 
transplant. Given improvements in donor risk profile and the anticipated shortage of suitable 
deceased donors, non-directed altruistic donation could facilitate sustainability as uterine 
transplantation moves from research into the clinical realm. The aim of this manuscript is to 
determine perceptions and identify motivations of potential altruistic non-directed living 
uterus donors and assess acceptability and suitability. 
Methods: A cross sectional survey utilising an electronic questionnaire amongst women who 
have enquired about donating their uterus for uterine transplantation.  
Results: The majority of respondents ‘strongly agreed’ or ‘agreed’ that the most prevalent 
motivations to donate their uterus include helping someone carry and give birth to their own 
baby (n=150;99%), helping others (n=147;97%), and because they no longer need their womb 
(n=147;97%). After considering risks of uterus donation, the majority were still keen to 
donate their uterus (n=144;95%), but following a process of exclusion using donor selection 
criteria, less than a third (n=42;29%) were found to be suitable to proceed.  
Conclusions: This study demonstrates novel insight into the motivations of women who wish 
to donate their uterus and displays high levels of acceptability after consideration of the risks 
involved. Despite the physical risk and transient impact upon ability to undertake activities of 
daily living, women who donate their uterus expect to gain psychological and emotional 
benefits from enabling another woman to gestate and give birth to their own future children. 






The first livebirth following uterine transplantation (UTx) was reported in 2014.1 More than 
70 cases have now been performed worldwide, and outcomes have recently been reported 
from 45 cases, which have yielded nine livebirths so far.2 UTx has thereby been proven a 
feasible fertility restoring intervention for women with absolute uterine factor infertility 
(AUFI), allowing them to conceive and gestate their future children. UTx is a non-vital, 
quality-of-life enhancing solid organ transplant. The non-essential nature of a uterus after the 
completion of one’s family allows the opportunity to use both living donors (LD) and 
deceased donors (DD). Each donor type presents ethical, logistical, physiological, 
immunological and anatomical advantages and disadvantages that continue to stimulate 
debate.3,4 LD can either be directed or non-directed in nature. Directed organ donations 
include the donation of an organ that is intended for a specific individual, from someone with 
an emotional or biological relationship, such as a friend or close family member. Conversely, 
non-directed donations are from donors with no such pre-existing relationships and are 
unknown to the recipient. 
 
The greatest advantage of DD is that while LD necessitates and risks significant physical and 
psychological harms to donors, DD completely avoids these harms and risks. In LD UTx 
cases so far, more than one in ten donors have suffered a complication necessitating further 
surgical intervention,2 including ureteric injuries,5,6,7 faecal impaction requiring digital 
evacuation under anaesthesia,8 and vaginal cuff dehiscence.9 Around a quarter of donors have 
suffered less serious complications including wound infection,7 bladder hypotonia,6 urinary 
tract infection,2 leg/buttock pain, depression,9 intubation related respiratory failure and 
anaemia.2 The risks associated with LD are however expected to diminish over time as 
surgical techniques and selection criteria are finessed. Recent modifications to the vascular 
dissection process have, for example, reduced surgical risks and operative times,2 by 
prioritising ovarian venous drainage where possible,6,9-11 as opposed to the uterine venous 
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complex.7 Similarly, the implementation of minimally invasive surgical techniques in recent 
cases, offers further risk reduction and an enhanced recovery process.11-13 
The ethics literature on UTx discusses the risks associated with LD as well as concerns 
regarding consent and the potential for donor regret.14-16 This has led many to conclude that 
DD is preferable provided that there are sufficient donor uteri, similar success rates, and that 
retrieval does not threaten the viability of lifesaving organs for transplant.17-19 Where these 
conditions are not met however the use of living donors may be justified provided that the 
donor provides informed and voluntary consent, the risks are proportionate to potential 
benefits and fall below an acceptable absolute threshold, and risks to the donor are 
minimised.17 This is similar to the approach adopted in other solid organ transplants that use 
LD such as kidney and liver lobe transplantation. 
 
Given improvements in donor risk profile and the anticipated shortage of suitable deceased 
donors,20 a combination of both LD and DD will likely be needed in the short to medium-
term.21 In the context of LD, reliance solely on directed donations could exclude potential 
recipients who do not have a willing and suitable donor among their friends or family 
members. Therefore, as is the case in other solid organ transplants, allowing non-directed 
altruistic donation from donors previously unknown to the recipient could facilitate 
sustainability as UTx progresses from research into the clinical realm. However, non-directed 
living organ donation raises ethical concerns regarding the potential for undue inducement 
and defective understanding.22 Despite this, some scholars have suggested that non-directed 
donation could be preferable to directed donation, since the use of donors known to recipients 
brings with it the risk of undue pressure to donate from family members or friends.16,23 
 
In the light of this, the primary aim of this study was to identify the perceptions of potential 
donors toward uterus donation, and evaluate their motivations underpinning their desire to 
donate. Secondly, investigation of their suitability, as well as determination of acceptability 
and willingness to proceed was also evaluated, after disclosure and discussion of the risks 
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associated with donation, expected recovery period and process, and its potential impact upon 
their lives.  
 
Materials and Methods 
 
Study Design 
This study was developed as a direct response to demand from women who contacted Womb 
Transplant UK to enquire about the possibility of altruistic uterus donation. All women who 
contacted Womb Transplant UK (Registered Charity no.1138559) to enquire about donating 
their uterus between 1st November 2014 and 1st November 2019 were invited to participate. 
An email containing a link to an electronic questionnaire, as well as two information leaflets, 
was sent to potential participants. One information leaflet detailed the conduct of the study 
while the other explained the proposed process of LD UTx (Supplemental Appendix 1). The 
questionnaire contained an initial 4-question consent process, which required agreement prior 
to proceeding to the 58-question questionnaire (Supplemental Appendix 2). The online 
platform SurveyMonkey® was used to distribute the questionnaire, over a six-month period 
between 1st June 2019 and 31st November 2019. Initial questions elicited demographic 
information before determining background medical, surgical, psychiatric, obstetric, 
gynaecological and social history. Further questions ascertained perceptions of adoption, 
surrogacy, and knowledge and opinions of UTx. Subsequent questions specifically assessed 
acceptability of the necessary pre-operative investigations, the potential need for hormone 
supplementation in post-menopausal donors, and willingness to donate after considering the 
risks and expected recovery time of uterus donation. The final questions determined 
knowledge and perceptions of potential recipient risk, views on the provision of updates 
regarding recipient progress post-transplant, and financial considerations. Most questions 
were closed, utilising tick boxes, with the option to include further comment in cases where 
further description was warranted. Likert scales were used in questions related to perceptions. 
A number of women were consulted in the creation of the information leaflets and 
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questionnaire to help refine questions, content and phraseology. The questionnaire was 
further piloted amongst a sample of potential donors to assess understanding and readability. 
 
Ethics approval 
Ethics approval was received from Imperial College Research Ethics Committee on 30th May 
2019 (ICREC reference: 19IC5202) 
 
Data analysis 
SPSS version 24 software (SPSS, Chicago, Illinois, USA) was used for analysis. Descriptive 
statistical analysis was described as mean +/- SD or median +/- range. The Likert scale 
responses were quantified using a weighted ranking system to ascertain the most influential 
perceived factor (0 = not at all; 4 = definitely).  
 
Results 
285 women approached the charity regarding the possibility of donating their uterus. 152 
women subsequently completed the questionnaire, resulting in a response rate of 53.3%. The 
cohort comprised of 151 women and one female to male transgender man. The demographics 
of the respondents are summarised in Table 1. The most prevalent age group was 30-39 years 
old (33%; n=50). The majority of respondents were Caucasian (94%; n=143), fluent in 
English (99%; n=151), married (50%; n=76) and in either full/part time employment or self-
employed (68%; n=103). A minority (16%; n=24) were current smokers, 30% were ex-
smokers (n=45) and the remainder had never smoked (55%; n=83).  
 
Medical history 
Table 2 summarises the obstetric background of our cohort. Over a third were nulliparous 
(37% n=56). Of those who had children previously (n=96), around three quarters (n=70; 73%) 
delivered their children vaginally, while the remainder had at least one child born by 
Caesarean section (n=26; 27%). Of those who had previously had Caesarean sections 13% 
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(n=12) had one; 11% (n=11) had two; and 3% had ≥ 3. More than three quarters of those with 
previous pregnancies had not experienced significant antenatal or postnatal complications 
(n=74; 77%). The most frequently encountered obstetric complication was pre-term delivery, 
which impacted 11% (n=11). 
 
Around a quarter of our cohort had previously experienced miscarriages (n=37; 24%), and 5% 
(n=8) had experienced ≥3. 17% (n=26) of respondents were post-menopausal. Of those still 
menstruating 84% (n=106) reported regular cycles and 16% (n=20) reported irregular cycles. 
Nearly a quarter of participants had previous abnormal cervical cytology (n=34; 22%). 50% 
of this number subsequently underwent surgical treatment (n=17) and 50% were monitored 
conservatively (n=17) and 97% (n=33) had normal cytology since.  
 
The mean BMI of participants was 28.4kg/m2 +/- 8.56. 61% (n=93) did not report any 
significant medical history. The previous medical, psychological and abdomino-pelvic 
surgical history of participants is summarised in Table 3. Only one individual reported a 
previous history of malignancy, which affected her breast. None of the women in this cohort 
were known to be HIV positive, or to have syphilis or hepatitis. Around half reported other 
minor medical conditions, which would not impact suitability to donate their uterus (n=29; 
49%). Over three quarters of participants did not have any previous psychiatric history 
(n=116; 76%). The majority of the cohort had not previously undergone abdomino-pelvic 
surgery (n=90; 59%).  
 
Understanding and perceptions of uterine transplantation 
Although 79% (n=120) of individuals ‘strongly agreed’ or ‘agreed’ that adoption and 
surrogacy were suitable methods to have children, all participants (n=152; 100%) felt that 
women should be freely able to voluntarily donate their uterus for UTx if adequately 
informed of the process. The majority of respondents reported knowing ‘a fair amount’ or ‘a 
lot’ about UTx (n=88; 58%), around a third had ‘heard it discussed only a few times’ (n=52; 
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34%) and a minority admitted to ‘knowing nothing’ (n=12; 8%). The majority of individuals, 
however, ‘strongly agreed’ or ‘agreed’ that they understood the potential benefits (n=143; 
94%) and risks (n=131; 86%) of uterus donation.  
 
Nearly all respondents ‘strongly agreed’ or ‘agreed’ that they would consent to undergoing 
the necessary pre-operative investigations (n=150; 98%), and held the expected recovery 
process, including a four-day inpatient admission and an 8-week recovery period, to be 
acceptable (n=148; 97%). All but one respondent understood that future pregnancies in the 
recipient would not be genetically related to the uterus donor (n=151; 99%). All participants 
reported completion of their family (n=152), with over a third of these being nulliparous 
(n=55; 36%). All premenopausal respondents understood that they would be unable to gestate 
a pregnancy after uterus donation (n=126). The majority of these understood that the intended 
operation involved ovarian conservation, which would result in normal hormone levels post-
operatively (n=121; 96%). 96% of respondents (n=122) ‘strongly agreed’ or ‘agreed’ that 
donation of their uterus would cease future menstruation and the majority ‘strongly agreed’ or 
‘agreed’ that cessation of menstruation would improve their quality-of-life (n=113; 89%). Of 
those participants who were postmenopausal (n=26), the majority ‘strongly agreed’ or 
‘agreed’ that they would accept 3-6 months of hormone replacement therapy to demonstrate 
endometrial function by inducing withdrawal bleeds pre-operatively (n=24; 92%).  
 
Motivations for uterine donation  
Factors motivating consideration of uterus donation are depicted in Figure 1. The 
overwhelming majority of respondents ‘strongly agreed’ or ‘agreed’ that they were motivated 
to donate to: help someone else carry and give birth to their own baby (n=150; 99%); help 
others (n=147; 97%); and because they no longer need their womb (n=147; 97%). Nearly 
three quarters of the cohort ‘strongly agreed’ or ‘agreed’ that they were already an organ 
donor and wanted to donate another organ (n=110; 72%). 20% (n=30) ‘strongly agreed’ or 
‘agreed’ that they wanted to donate due to previously considering or being a surrogate. Only 
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15% (n=23) of the cohort ‘strongly agreed’ or ‘agreed’ to personally knowing someone 
infertile who they wanted to donate their uterus to. Using a weighted scoring system, Figure 
2 represents the importance respondents placed on each influencing factor. The two most 
influential factors were the desire to help someone else carry and give birth to a child and 
wanting to help others. The least influential factors were personally knowing someone who 
was infertile that they wanted to donate to, and wanting to donate due to considering or being 
a surrogate previously.  
 
More than three quarters (n=117; 77%) of respondents were aware that UTx recipients would 
be at greater risk of malignancy and infection due to the immunosuppressive medications 
required to be taken post-operatively. However, just 9% (n=14) agreed or strongly agreed that 
this knowledge would impact their decision to donate. More than two thirds of the cohort 
wanted to be kept informed of future progress of recipients of their uteri (n=105; 69%), 
around a quarter (n=40; 27%) were undecided and 3% (n=5) would not want to know. Most 
respondents ‘strongly agreed’ or ‘agreed’ to understanding they would not receive any 
payment for donating their uterus (n=145; 95%), however four (2%) individuals ‘strongly 
disagreed’ or ‘disagreed’. Given the likely media interest in the process due to its novelty, the 
majority (n=129; 85%) ‘strongly agreed’ or ‘agreed’ that uterus donation would risk 
unwanted media attention. 
 
After reading the information and considering the risks, nearly all participants were still keen 
to donate their uterus (n=144; 95%). Eight (4%) remained undecided, with the majority 
expressing a desire to know further information. One participant, however, disagreed, citing 
the desire for further counselling to help not develop an attachment to the recipient’s family. 
 
Suitability  
Figure 3 summarises a systematic process of exclusion, utilising the donor selection criteria 
we have implemented for the UK UTx LD programme (Table 4). In accordance with this 
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criterion 25 (17%) respondents would be excluded from uterus donation due to age ≥60 or 
BMI>35kg/m2. 17 (12%) more would be excluded for being current smokers. A further 11 
(8%) would be excluded due to significant pre-existing medical conditions and four (3%) 
more would be excluded due to multiple or significant previous surgical history. More than a 
quarter (n=38; 26%) would not be eligible due to nulliparity, previous preeclampsia, or 
preterm delivery. Three (2%) respondents would be considered unsuitable due to recurrent 
miscarriage, and four (3%) would be excluded due to previous cervical surgery for abnormal 
cells, or a recent abnormal cytology result. Following implementation of the selection criteria, 
42 respondents (29%) would be considered suitable to proceed with further clinical 
evaluation, counselling and further investigation to determine suitability to donate.  
 
Discussion 
The data presented herein demonstrates novel insight into the perceptions of potential UTx 
living donors and portrays robust and diverse motivations and desires to proceed with the 
donation process following understanding of the risks involved and a realistic awareness of 
the expected process and recovery. This reinforces the generally supportive previously 
reported public perceptions of UTx. When considering the public, a web-based questionnaire 
completed by 1247 US residents identified that more than three quarters (78%) supported 
UTx.24 Similar levels of support were seen in a European study including 2000 Swedish 
women, where 80% were found to be in favour of UTx and considered it to be more 
acceptable than surrogacy.25 However, a study in 3098 women of reproductive age in Japan 
demonstrated less favourable support, with just 44.2% being in favour of UTx. However, 
47.5% had no opinion, which highlights a potential lack of awareness of UTx in those 
surveyed, particularly when the vast majority (93.3%) felt that UTx should be permitted 
either with, or without further discussion.26 In the context of DD, more than a decade ago, 
before the first livebirth following UTx was reported,1 just 6% of donor families agreed to 
uterine procurement as part of deceased donation.27 However, 10 years later, attitudes to 
uterine donation appear to have improved, with three quarters of women agreeing to donation 
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of their uterus at the time of their death, which increased to 87% after becoming informed 
about the purpose of the transplant 28 In addition, a recent European study demonstrated that 
donation of the uterus was readily accepted, with no refusals observed in seven cases.29  
 
In the context of LD, it is essential to understand prospective donors’ motivations and 
expectations in order to ensure both comprehension of the harms, risks and likely benefits of 
the procedure on the part of the donor, and that willingness to donate is not coerced or 
induced, for example with expectation of payment. As shown in the data presented herein, 
nearly all respondents appeared to understand that they would not receive payment for their 
donation, which is reassuring. Prospective living donors should be nonetheless provided with 
clear information regarding the financial implications of a decision to donate such as the 
prohibited status of payment for organs and any reimbursement they may claim to offset the 
costs of donation. 
 
If of childbearing age, potential donors’ future reproductive plans need to be explored, as 
does the possibility that their aspirations and plans could change if they met a new partner in 
future. We demonstrate that, of those included in the survey, the most common motivation for 
donation was to help someone else carry and give birth to a child, closely followed by a desire 
to help others which is consistent with the primary reported motivations underpinning 
donation in the first six non-directed UTx donors in the Dallas UtErine Transplant Study 
(DUETS).30 Moreover, this is in line with motivations expressed in the non-directed donation 
of other organs, such as kidney donation, where the desire to donate has been described by 
donors as ‘compelling’, and donation is associated with significant psychological motives and 
gains.31 Qualitative interviews with non-directed kidney donors identified that donors want to 
offer someone else a chance at a normal life,32 and that the altruistic value gained from the 




Our findings however also suggest that the underpinning motives of potential living uterus 
donors may be mixed, with further consideration of self-regarding interests. A significant 
majority of respondents (89%) ‘agreed’ or ‘strongly agreed’ that the cessation of menstruation 
would improve their quality of life, suggesting that they would expect physical benefits from 
donation. This inference is supported by work exploring the motivations of living organ 
donors more generally which shows that, despite the narratives often imposed on them, 
“many organ donors are not pure altruists: willing to sacrifice their own interests or the sake 
of another with no expectation of, or desire for, benefit… they hold mixed and complicated 
motivations for donation”.22  
 
We also clearly demonstrate the anticipated decline in numbers of potential donors in the 
context of using proposed standard donor criteria. These figures can be used to estimate 
eventual donor availability and also manage expectations in potential UTx donors. In 
DUETS, 79 women initially expressed interest in donating their womb and 62 were 
subsequently screened by telephone.34 Following pre-screen, 30 donors completed a detailed 
health history questionnaire, in a similar fashion to our study, where 12 women eventually 
proceeded to be clinically evaluated.34 This presents an overall conversion from screening to 
being clinically evaluated of 19%, which compares to 28% in our cohort. In DUETS, 
following clinical evaluation, 50% of potential donors eventually proceeded with donation 
(n=6), due to a combination of unsuitability or self-withdrawal. Thereby, within our cohort, 
utilising a 50% dropout rate, it would be anticipated that approximately 21 women may 
eventually be suitable to proceed with donation from the initial 152 women.  
 
In UTx cases performed internationally so far, the mean age is 44 years, and the mean age of 
the potential donors evaluated in DUETS was 40 years old.2 Whilst the precise ages were not 
elicited in this dataset, as 61% of the cohort were aged between 30-50, they appear broadly 
similar. In UTx cases performed so far, the vast majority (93%) have had children previously, 
which is likely to have been skewed following multiparity being an initial recommended 
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inclusion criteria for donors, as it is the only way to demonstrate uterine functionality with 
certainty.35 However, 90% of the potential donors evaluated in DUETS were also 
multiparous, which is significantly higher than the 63% demonstrated herein. This identifies 
that despite more than a third of our cohort not having children themselves, they still had 
insight into the potential benefits of donating their uterus to someone who desires children.  
 
While the use of marginal organs is acceptable in life-saving organ transplants, owing to the 
significant risk of death while on transplantation waiting lists,36 it is harder to justify the use 
of suboptimal grafts in quality-of-life improving transplants, such as UTx. However, it is 
currently difficult to determine which donor selection criteria result in a suboptimal graft. 
Although various selection criteria have been utilised in trials to date, ongoing discussion in 
the context of outcomes following UTx is required to determine which criteria optimise graft 
quality, and which criteria are of negligible benefit and therefore unnecessarily limit donor 
availability. Recent donor criteria have been suggested for implementation in the context of 
DD.37 If extrapolated into LD, their suggested standard donor criteria, which excludes women 
with miscarriage or Caesarean section, would reduce the number of suitable donors to just 25, 
before comprehensive clinical evaluation and investigation, representing just 16% of the 
initial cohort. Given that the majority of miscarriages are sporadic and due to problems 
completely unrelated to the uterus, such as embryonic aneuploidy,38 and that 15-20% of 
women experience miscarriage,39 accepting donors with previous sporadic miscarriages could 
increase donor availability without detracting from the quality of the graft. Moreover, given 
that around a quarter of deliveries in the UK are performed via Caesarean section, removing 
this as an exclusion would improve donor availability.  
 
This is the largest study of its kind to determine the background, perceptions and motivations 
of potential UTx living donors, and the first of its kind in a UK population. Its findings 
demonstrate that non-directed altruistic donation could be a solution to the anticipated 
shortage of deceased donors, and lack of availability of living-related donors for women with 
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AUFI. A weakness of this study includes the fact participants were self-selected, since they 
all directly contacted Womb Transplant UK to enquire about uterine donation. As such, the 
results presented herein are not directly applicable to all women, but relate specifically to 
women interested in donating their uterus. Additionally, the exclusive use of self-reported 
data and closed-ended questions introduces the potential for bias.  
 
Altruistic non-directed LD UTx donation appears to be ethically and medically acceptable, 
provided that comprehensive physiological and psychological donor evaluation is undertaken 
pre-operatively, donor risk is minimised as much as possible, and donors are appropriately 
counselled, thereby facilitating informed consent. As suggested by the findings presented 
here, donating an organ can generate a number of psychological and emotional benefits and 
most potential UTx donors express a desire to give another woman the opportunity to bear a 
child herself. Moreover, in the context of the reported outcomes in cases performed to date, 
albeit limited in number, it is reassuring that psychological outcomes appear excellent, and 
that little regret has so far been reported.8,40  
 
While the use of DD negates donor risk, the associated logistical difficulties are so complex 
that they can compromise the viability of UTx programmes.4 Moreover, even in healthcare 
systems with well-established DD programmes, concerns have been expressed about the 
potential availability of donors to meet future demand.21,37 Although increasing donation after 
brain death conversion rates is essential, increasing potential DD supply may also be possible 
by considering uterine donation after cardiac death. However, this is a prospect that requires 
further research, to determine whether the prolonged warm ischaemic time in such cases is 
detrimental to UTx outcomes. As demonstrated herein, given the willingness of some women 
wishing to donate their uterus to an unknown recipient, the use of altruistic non-directed UTx 








This study provides novel insight into the motivation of women who wish to donate their uterus 
to a previously unknown recipient and displays high levels of acceptability after consideration 
of the risks and expected recovery. Despite the physical risk and expected lengthy recovery 
process, women who donate their uterus expect to gain psychological and emotional benefit by 
enabling another woman to bear a child. In the context of expected shortages in DD availability, 
unnecessarily ruling out non-directed LD is not ethical, nor is it sustainable. As such, 
consideration of the use of non-directed altruistic living donation offers an alternative, 
following comprehensive medical and psychological assessment and extensive counselling. 
However, as demonstrated here, despite the desire and motivation to donate, the selection 
criteria currently being implemented reduce the number of potential donors significantly. While 
enhancing outcomes remains paramount, further work is needed to validate selection criteria in 
order to optimise donor availability without impacting graft quality.  
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